Omeprazol Aurovitas (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Aurovitas, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults and children. GNH USA supplies Omeprazol Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. It is used in several clinical situations:

- Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of the oesophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - NSAID‑associated ulcer prevention: reduces risk of ulcer development in patients requiring long‑term NSAID therapy.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: infrequent.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: kidney inflammation. - Hypomagnesemia: low serum magnesium levels. - Osteoporotic fractures: increased risk with long‑term use. - Stevens‑Johnson syndrome: rare severe skin reaction. - Hepatic injury: elevated liver enzymes or hepatitis.

When using Omeprazol Aurovitas, consider the following precautions:

- Assess renal function: adjust use in severe renal impairment. - Monitor magnesium levels: long‑term therapy may cause hypomagnesemia. - Evaluate bone health: prolonged use may affect calcium absorption. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Pregnancy and lactation: weigh benefits against potential risks. - Store at ambient temperature: keep in original packaging, protect from moisture.

Omeprazole may interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atorvastatin: increased plasma concentration. - Warfarin: potential increase in INR.

Moderate Interactions (Monitor Closely): - Digoxin: altered absorption may require level monitoring. - Methotrexate: increased serum levels, especially with high‑dose regimens. - HIV protease inhibitors (e.g., ritonavir): altered plasma concentrations.